NCT00955110View on ClinicalTrials.gov

Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Healthy
Interventions
DRUG

Oxymorphone ER

15mg or 30mg

DRUG

Oxycodone CR

30mg or 60mg

DRUG

Placebo

The placebo was a sugar pill.

DRUG

Hydromorphone

8 mg

Trial Locations (1)

Unknown

Toronto

Sponsors
All Listed Sponsors
collaborator

Kendle Early Stage - Toronto

OTHER

lead

Endo Pharmaceuticals

INDUSTRY